NDC properties for "adalimumab-adbm 40 MG per 0.8 ML Auto-Injector" (RxCUI 2640895)
About this data
The tables show NDC propoerties for adalimumab-adbm 40 MG per 0.8 ML Auto-Injector with the RxCUI 2640895
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for adalimumab-adbm 40 MG per 0.8 ML Auto-Injector (RxCUI 2640895)
| BLA | BLA761058 |
|---|---|
| MMSL_CODE | BD32554 |
| RxCUI | 2640895 |
| SPL_SET_ID | 62f39a7c-00df-4519-a8d4-39bbd0a649ed |
| SPL_SET_ID | f9986706-9c75-4335-a54f-09d7716dbcef |
| VUID | 4042370 |
| Prescribable Synonym | adalimumab-adbm 40 MG in 0.8 ML Auto-Injector |
| RXNAV_STR | 0.8 ML adalimumab-adbm 50 MG/ML Auto-Injector |
| RxNorm Name | 0.8 ML adalimumab-adbm 50 MG/ML Auto-Injector |
| RxNorm Synonym | adalimumab-adbm 40 MG per 0.8 ML Auto-Injector |
| Related queries | Interactions (for RxCUI 2640895) |
NDC Properties
NDC Item 00597054522
| NDC 9 | 0597-0545 |
|---|---|
| NDC 10 | 0597-0545-22 |
| NDC Item | 00597054522 |
| Packaging | 2 KIT in 1 CARTON (0597-0545-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (0597-0540-10) / .8 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784593 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0545 |
NDC Item 82009014822
| NDC 9 | 82009-148 |
|---|---|
| NDC 10 | 82009-148-22 |
| NDC Item | 82009014822 |
| Packaging | 2 KIT in 1 CARTON (82009-148-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (82009-149-11) / .8 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784783 |
| Labeler | QUALLENT PHARMACEUTICALS HEALTH LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82009-148 |
NDC Item 82009014911
| NDC 9 | 82009-149 |
|---|---|
| NDC 10 | 82009-149-11 |
| NDC Item | 82009014911 |
| Packaging | 0.8 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| FDA SPL set id | 784783 |
| Labeler | QUALLENT PHARMACEUTICALS HEALTH LLC |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 82009-149 |
NDC Item 00597054522
| NDC 9 | 0597-0545 |
|---|---|
| NDC 10 | 0597-0545-22 |
| NDC Item | 00597054522 |
| Packaging | 2 KIT in 1 CARTON (0597-0545-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (0597-0540-10) / .8 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784593 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0545 |
NDC Item 82009014822
| NDC 9 | 82009-148 |
|---|---|
| NDC 10 | 82009-148-22 |
| NDC Item | 82009014822 |
| Packaging | 2 KIT in 1 CARTON (82009-148-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (82009-149-11) / .8 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784783 |
| Labeler | QUALLENT PHARMACEUTICALS HEALTH LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82009-148 |
NDC Item 82009014911
| NDC 9 | 82009-149 |
|---|---|
| NDC 10 | 82009-149-11 |
| NDC Item | 82009014911 |
| Packaging | 0.8 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| FDA SPL set id | 784783 |
| Labeler | QUALLENT PHARMACEUTICALS HEALTH LLC |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 82009-149 |
NDC Item 00597054522
| NDC 9 | 0597-0545 |
|---|---|
| NDC 10 | 0597-0545-22 |
| NDC Item | 00597054522 |
| Packaging | 2 KIT in 1 CARTON (0597-0545-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (0597-0540-10) / .8 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784593 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0545 |
NDC Item 82009014822
| NDC 9 | 82009-148 |
|---|---|
| NDC 10 | 82009-148-22 |
| NDC Item | 82009014822 |
| Packaging | 2 KIT in 1 CARTON (82009-148-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (82009-149-11) / .8 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784783 |
| Labeler | QUALLENT PHARMACEUTICALS HEALTH LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82009-148 |
NDC Item 82009014911
| NDC 9 | 82009-149 |
|---|---|
| NDC 10 | 82009-149-11 |
| NDC Item | 82009014911 |
| Packaging | 0.8 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| FDA SPL set id | 784783 |
| Labeler | QUALLENT PHARMACEUTICALS HEALTH LLC |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 82009-149 |